Preparation and Characterization of the Inclusion Complex of Furosemide with Hydroxypropyl-β-Cyclodextrin

Abstract

A highly hydrophobic drug, furosemide, was treated with 2-Hydroxypropyl-β-Cyclodextrin in an attempt to produce modified compounds with increased water solubility. Following a freeze-drying process, the interactions of furosemide and cyclodextrin led to the formation of an inclusion complex, whose dissolution rate in water was studied by the solubility method. Furthermore, mechanical mixtures of furosemide and cyclodextrin were also prepared and tested for their solubility. The reaction products were characterized in the solid state by differential scanning calorimetry (DSC), which provided some evidence about complexation. Additional evidence was obtained by recording the ¹HNMR spectra of aqueous solutions of these same products. The study of phase solubility was based on the Higuchi & Connors method and showed an impressive enhancement of the miscibility of furosemide with water. In fact, a 11 fold increase of the drug solubility was recorded for the inclusion complex, in the first stages of dissolution. The experimental results of this work show that 2-Hydroxypropyl-β-Cyclodextrin isan efficient complexation agent for furosemide. Combination of those two substances can be carried out by simple techniques, providing easy control and the obtained inclusion complex is characterized by acceptable water solubility and increased dissolution rate.

Keywords

furosemide 2-Hydroxypropyl–β–Cyclodextrin complexation dissolution characterization freeze-drying process

Get full access to this article

View all access options for this article.

References

1. Martindale, W. (1993). The Extra Pharmacopoeia, 30th Edn., The Pharmaceutical Press, England.

2. Uekama, K. , Fujnaga, T. , Hirayama, F. , Otagiri, M. and Yamasaki, M. (1982). Inclusion Complexations of Steroid Hormones with Cyclodextrins in Water and in Solid Phase, Int. J. Pharm., 10: 1–15.

3. Corrigan, O. and Stanly, T. (1982). Mechanism of Drug Dissolution Rate Enhancement from Beta-Cyclodextrin-Drug Systems, J. Pharm. Pharmacol., 34: 621–626.

4. Pederson, M. (1994). Isolation and Antimycotic Effect of a Genuine Miconazole β-Cyclodextrin Complex, Eur. J. Pharm. Biopharm., 40: 19–23.

5. Uekama, K. , Hirayama, F. and Irie, T. (1991). Pharmaceutical Uses of Cyclodextrin Derivatives. High Performance Biomaterials, A Comprehensive Guide to Medical and Pharmaceutical Applications, pp. 789–806, Technomic Publishing Co., Pennsylvania.

6. Amamr, H.O. , Ghorab, M. , Emara, L.H. , El-Nahhas, S.A. and Makram, T.S. (1999). Inclusion Complexation of Furosemide in Cyclodextrins, Pharmazie, 54: 207–210.

7. Hirayama, F. , Wang, Z. and Uekama, K. (1994). Effect of 2-Hydroxypropyl-β-Cyclodextrin on Crystallization and Polymorphic Transition of Nifedipine in Solid State, Pharmaceutical Research, 11: 1766–1772.

8. Szente, L. and Szejtli, J. (1999). Highly Soluble Cyclodextrin Derivatives: Chemistry, Properties and Trends in Development, Adv. Drug, Deliv. Rev., 36: 17–28.

9. Gramera, R.E. and Caimi, R.J. (August 1969). U.S. Patent 3, 459, 731.

10.

10. Pitha, J. and Pitha, J. (1985). Amorphous Water Soluble Derivativesof Cyclodextrins: Nontoxic Dissolution Enhancing Excipients, J. Pharm. Sci., 74: 987–990.

11.

11. Higuchi, T. and Connors, K. (1965). Phase Solubility Techniques, Adv. Anal. Chem. Instrum., 4: 117–212.

12.

12. Loukas, Y. (1995). Complexation of Haloperidol with a Water-soluble β-Cyclodextrin Polymer: Characterization of the Inclusion Complex in Solid State and in Aqueous Solution, Pharm. Sci., 1: 509–512.

13.

13. Loukas, Y. , Antoniadou-Vyza, E. , Machera, E. and Papadaki, A. (1994). γ-Cyclodextrin Inclusion Complex of a New Organophosphorus Insecticide, Determination of Stability Constant with HPLC, J. Agr. Food Chem., 42: 944–988.

14.

14. Esclusa-Diaz, M. , Gayo-Otero, M. , Perez-Marcos, M. , Vila-Iato, J. and Torres-Labandeira, J. (1996). Preparation and Evaluation of Ketoconazole-β-Cyclodextrin Multicomponent Complexes, Int. J. Pharm., 142: 183–187.

15.

15. Connors, K.A. (1987). Binding Constants: The Measurement of Molecular Complex Stability, 1st Edn., pp. 261–283, Wiley and Sons, New York.